Title: Global Allergic Conjunctivitis Market Outlook
1Global Allergic Conjunctivitis Market
2Report Description and Highlights
Analyst View According to Renub Research
analysis the Allergic Conjunctivitis Market will
exceed US 2 Billion mark by the end of
year 2025. Allergic conjunctivitis unusually
caused when a persons eye comes in contact with
an allergen (substances that cause allergies,
like pollen, chemicals, dirt or mold spores) as
the conjunctiva is prone to irritation from
allergens. The eye becomes inflamed and sore. In
conjunctivitis, the tissue (conjunctiva) that
lines inside of the eyelid and the white of the
eyeball that keeps the eyeball and eyelid moist
became inflamed. Conjunctivitis is one of the
most common and treatable eye conditions. There
are two types of conjunctivitis namely allergic
and infective conjunctivitis. Further, allergic
conjunctivitis is classified as acute and chronic
conjunctivitis. Acute conjunctivitis is a short
term condition and can cause generally during
allergy season while chronic conjunctivitis can
occur year-round and has a milder response to
allergens. Common symptoms of chronic
conjunctivitis include same as acute
conjunctivitis i.e. burning and itching of the
eyes and light sensitivity but it comes and goes
more frequently.
3Global Allergic Conjunctivitis Market
Allergic conjunctivitis is different from
infective conjunctivitis as the cause is
different. Allergic conjunctivitis is not
contagious like the infective one. So it is vital
to know whether the affected person have allergic
or infective conjunctivitis since treatment for
each condition is different. In the latest Renub
Research report, Allergic Conjunctivitis Market,
the report offers an in-depth primer of its
upcoming market including how the allergic
conjunctivitis market has grown and what it holds
for the future, along with the key factors that
are driving the market growth and challenges
which are restraining the market
growth. Irrespective of age, one who is
susceptible to allergens, are more likely to
develop allergic conjunctivitis, mostly the
children and young adults. According to the
Asthma and Allergy Foundation of America,
allergies affect nearly 30 percent of adults and
40 percent of children and often run in families.
If anyone who have allergies and live in
locations with high pollen counts, they are more
prone to allergic conjunctivitis. Read more
here https//www.renub.com/allergic-conjunctivit
is-market-p.php
4Global Forecast for Allergic Conjunctivitis
Disease Type Market Share 2019 2025
Global Forecast for Allergic Conjunctivitis
Disease Type Market Share ()
Source Renub Research Analysis Note These are
dummy figures actual data given in the report
5Global Allergic Conjunctivitis Market Summary
- Market Summary
- Patient Population wise, China dominates the
global allergic conjunctivitis patient
population. The report provides patient
population population share for following
countries India, China, Japan, United States,
United Kingdom, France, Germany, Italy and Spain. - Country wise market, United States is the
leading country in the global allergic
conjunctivitis market. This research report
covers following market and market share of
following countries India, China, Japan, United
States, United Kingdom, France, Germany, Italy
and Spain. - Disease type SAC and PAC holds largest
market share This research report covers
following diseases market and market share
Seasonal Allergic Conjunctivitis (SAC)
Perennial Allergic Conjunctivitis (PAC), Vernal
Keratoconjunctivitis (VKC), Atopic
Keratoconjunctivitis (AKC) And Giant Papillary
Conjunctivitis (GPC). - Drugs Profile and Pipe Line covered in the
report are, Zerviate, OTX-DP, ADX-102, PRT-2761,
CVXL-0074, AK-002, Bertilimumab, Reproxalap,
ST-266 and SYL-116011 etc. are in preclinical,
IND, Phase I, Phase II and Phase III stage. - Company-wise the report provides overview,
initiatives and financial insights of Santen
Pharmaceutical, Alcon (Novartis), Portola
Pharmaceuticals and Ocular Therapeutix. - Request a free sample copy of the report
- https//www.renub.com/request-sample-page.php?gtur
lallergic-conjunctivitis-market-p.php
6Global Allergic Conjunctivitis Market by Countries
Allergic Conjunctivitis Market by Countries, 2019
2025
Source Renub Research Analysis Note These are
dummy figures actual data given in the report
7Key Topics Covered in Allergic Conjunctivitis
Market
- Executive Summary
- 2. Global Allergic Conjunctivitis Market and
Patients Analysis - 2.1 Allergic Conjunctivitis Market2.2
Allergic Conjunctivitis Patient Numbers2.3
Allergic Conjunctivitis Treated Patient Numbers - 3. Share Analysis Global Allergic
Conjunctivitis - 3.1 Country Market Share3.2 Patients
Population Share3.3 Treated Patients
Population Share3.4 By Disease Type Share - 4. India
- 4.1 Allergic Conjunctivitis Patient
Numbers4.2 Allergic Conjunctivitis Treated
Patient Numbers4.3 Allergic Conjunctivitis
Market
8Key Topics Covered in Allergic Conjunctivitis
Market
5. China 5.1 Allergic Conjunctivitis
Patient Numbers5.2 Allergic Conjunctivitis
Treated Patient Numbers5.3 Allergic
Conjunctivitis Market 6. Japan 6.1
Allergic Conjunctivitis Patient Numbers6.2
Allergic Conjunctivitis Treated Patient
Numbers6.3 Allergic Conjunctivitis Market 7.
United States 7.1 Allergic Conjunctivitis
Patient Numbers7.2 Allergic Conjunctivitis
Treated Patient Numbers7.3 Allergic
Conjunctivitis Market
9Key Topics Covered in Allergic Conjunctivitis
Market
8. United Kingdom 8.1 Allergic
Conjunctivitis Patient Numbers8.2 Allergic
Conjunctivitis Treated Patient Numbers8.3
Allergic Conjunctivitis Market 9.
France 9.1 Allergic Conjunctivitis Patient
Numbers9.2 Allergic Conjunctivitis Treated
Patient Numbers9.3 Allergic Conjunctivitis
Market 10. Germany 10.1 Allergic
Conjunctivitis Patient Numbers10.2 Allergic
Conjunctivitis Treated Patient Numbers10.3
Allergic Conjunctivitis Market
10Key Topics Covered in Allergic Conjunctivitis
Market
11. Italy 11.1 Allergic Conjunctivitis
Patient Numbers11.2 Allergic Conjunctivitis
Treated Patient Numbers11.3 Allergic
Conjunctivitis Market 12. Spain 12.1
Allergic Conjunctivitis Patient Numbers12.2
Allergic Conjunctivitis Treated Patient
Numbers12.3 Allergic Conjunctivitis
Market 13. Disease Type Global Allergic
Conjunctivitis Market 13.1 Seasonal Allergic
Conjunctivitis (SAC) Perennial Allergic
Conjunctivitis (PAC)13.2 Vernal
Keratoconjunctivitis (VKC)13.3 Atopic
Keratoconjunctivitis (AKC)13.4 Giant
Papillary Conjunctivitis (GPC)
11Key Topics Covered in Allergic Conjunctivitis
Market
14. Global Allergic Conjunctivitis Drugs
Profile/Pipe Line Drugs 14.1 Zerviate 14.2
OTX-DP (Dexamethasone Insert) 14.3
ADX-10214.4 PRT2761 14.5
CVXL-0074 14.6 AK-00214.7
Bertilimumab 14.8 Reproxalap 14.9
ST-26614.10 SYL-116011 15. Growth
Driver 15.1 Rapid Urbanization and Growth of
Particulate Pollution15.2 Increasing Ageing
Population Widespread Use of Medications for
Various Eye Diseases 16. Challenges 16.1
Diagnostic Challenges16.2 Undertreated by
Patients
12Key Topics Covered in Allergic Conjunctivitis
Market
17. Santen Pharmaceutical 17.1 Company
Overview 17.2 Initiatives 17.3 Financial
Insight 18. Alcon Inc. (Novartis) 18.1
Company Overview 18.2 Initiatives 18.3
Financial Insight 19. Portola
Pharmaceuticals Inc. 19.1 Company
Overview 19.2 Initiatives 19.3 Financial
Insight 20. Ocular Therapeutix Inc. 20.1
Company Overview 20.2 Initiatives 20.3
Financial Insight If the information you seek
is not included in the current scope of the study
kindly share your specific requirements with
our custom research team at info_at_renub.com
13Global Allergic Conjunctivitis Market
Browse Related Report Epilepsy Drugs
Market Global Vitiligo Market Contact Us Tel
1-678-302-0700 (US), 91-120-421-9822
(INDIA) Email info_at_renub.com